Free Trial

Akre Capital Management LLC Decreases Stake in Danaher Corporation $DHR

Danaher logo with Medical background
Image from MarketBeat Media, LLC.

Akre Capital Management LLC lowered its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 92.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 69,516 shares of the conglomerate's stock after selling 805,315 shares during the quarter. Danaher comprises approximately 0.2% of Akre Capital Management LLC's holdings, making the stock its 16th largest holding. Akre Capital Management LLC's holdings in Danaher were worth $15,914,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Norges Bank purchased a new position in Danaher in the 4th quarter worth approximately $2,177,106,000. Viking Global Investors LP boosted its holdings in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate's stock worth $574,351,000 after acquiring an additional 2,455,994 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Danaher by 104.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate's stock worth $991,923,000 after acquiring an additional 2,216,789 shares during the period. Generation Investment Management LLP boosted its holdings in Danaher by 34.0% in the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate's stock worth $1,319,354,000 after acquiring an additional 1,689,020 shares during the period. Finally, Capital International Investors boosted its holdings in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate's stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

DHR stock opened at $179.95 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market cap of $127.37 billion, a P/E ratio of 34.81, a P/E/G ratio of 2.40 and a beta of 0.81. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The stock's 50 day simple moving average is $180.93 and its 200 day simple moving average is $204.78.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business's revenue was up 3.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.88 EPS. As a group, equities research analysts predict that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher's dividend payout ratio is currently 30.95%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Weiss Ratings restated a "hold (c)" rating on shares of Danaher in a report on Friday, March 27th. Rothschild & Co Redburn set a $205.00 price target on Danaher in a report on Friday, April 17th. TD Cowen cut their target price on Danaher from $245.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group reaffirmed a "buy" rating and issued a $245.00 target price on shares of Danaher in a research report on Tuesday, April 21st. Finally, Argus cut their target price on Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research report on Friday, April 24th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $233.61.

View Our Latest Report on DHR

Key Danaher News

Here are the key news stories impacting Danaher this week:

Danaher Company Profile

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines